SOURCE: SRI International

September 10, 2008 08:00 ET

SRI International to Present Case Studies on Outsourcing R&D at Annual BioLOGIC Europe Meeting

MENLO PARK, CA--(Marketwire - September 10, 2008) - SRI International, an independent nonprofit research and development organization, today announced that Walter H. Moos, Ph.D., vice president of SRI's Biosciences Division, will present at bioLOGIC Europe 2008. In his session, Dr. Moos will discuss outsourcing case studies and best practices in a presentation titled, "A nonprofit research institute's perspective on outsourcing R&D." The annual bioLOGIC Europe meeting will be held September 16-19 in Geneva, Switzerland.

To provide a clear perspective on outsourcing, Dr. Moos will highlight 10 case studies ranging from basic research and drug discovery to contract research and spin-outs and spin-ins. Together, these case studies will discuss the globalization of the research market, considerations for sourcing and researching, formulating an external research strategy, and effectively managing external relationships. Dr. Moos will also discuss key lessons learned through his extensive experience with various methods of outsourcing at SRI and other biotechnology and pharmaceutical organizations.

"Given today's costly and time-intensive drug development challenges, innovation and collaboration are essential for growth and survival," said Dr. Moos. "It is important to identify your company's strengths and to engage external experts who can efficiently help build your business. Depending on your needs and stage of growth, there is a range of models for collaboration, partnership and service."

In addition to his presentation, Dr. Moos will be one of three lecturers in a panel titled, "Considerations for building a successful pipeline including recent developments and perspectives." Joined by representatives from Genzyme Corporation and GlaxoSmithKline, Dr. Moos will discuss the use of regional initiatives to foster technology and pipeline development.

For more information regarding bioLOGIC 2008, please visit:

About SRI International

Silicon Valley-based SRI International ( is one of the world's leading independent research and technology development organizations. SRI, which was founded by Stanford University as Stanford Research Institute in 1946 and became independent in 1970, has been meeting the strategic needs of clients and partners for more than 60 years. Perhaps best known for its invention of the computer mouse and interactive computing, SRI has also been responsible for major advances in networking and communications, robotics, drug discovery and development, advanced materials, atmospheric research, education research, economic development, national security, and more. The nonprofit institute performs sponsored research and development for government agencies, businesses, and foundations. SRI also licenses its technologies, forms strategic alliances, and creates spin-off companies. In 2007, SRI's consolidated revenues, including its wholly owned for-profit subsidiary, Sarnoff Corporation, were approximately $450 million.

Contact Information

  • Media Contact:
    Lindsay Sheppard
    SRI International
    (650) 859-2491
    Email Contact